MAM
Monaco Asset Management Portfolio holdings
AUM
$264M
This Quarter Return
+16.02%
1 Year Return
+6.34%
3 Year Return
+31.77%
5 Year Return
–
10 Year Return
–
AUM
$280M
AUM Growth
+$280M
(+26%)
Cap. Flow
+$13.1M
Cap. Flow
% of AUM
4.67%
Top 10 Holdings %
Top 10 Hldgs %
55.92%
Holding
91
New
18
Increased
23
Reduced
16
Closed
15
Top Buys
| 1 |
LendingTree
TREE
|
$6.74M |
| 2 |
StoneCo
STNE
|
$5.9M |
| 3 |
Bank of Montreal
BMO
|
$4.05M |
| 4 |
Baidu
BIDU
|
$3.98M |
| 5 |
Zymeworks
ZYME
|
$3.93M |
Top Sells
| 1 |
Viatris
VTRS
|
$8.51M |
| 2 |
Alcoa
AA
|
$4.77M |
| 3 |
B
Barrick Mining Corporation
B
|
$4.3M |
| 4 |
GSK
GSK
|
$3.1M |
| 5 |
ProQR Therapeutics
PRQR
|
$2.84M |
Sector Composition
| 1 | Energy | 23.76% |
| 2 | Healthcare | 19.61% |
| 3 | Materials | 11.16% |
| 4 | Technology | 6.87% |
| 5 | Financials | 6.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FTCH
26
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $3.04M | 0.92% |
642,100
+412,100
| +179% | +$1.95M |
|
27
Esperion Therapeutics
ESPR
$448M
| $2.93M | 0.88% |
470,100
+210,100
| +81% | +$1.31M |
|
28
iShares China Large-Cap ETF
FXI
$6.65B
| $2.83M | 0.85% |
+100,000
| New | +$2.83M |
|
29
Kodiak Sciences
KOD
$478M
| $2.82M | 0.85% |
393,366
+66,155
| +20% | +$474K |
|
30
NOV
NOV
$4.94B
| $2.72M | 0.82% |
130,000
-130,000
| -50% | -$2.72M |
|
31
AngloGold Ashanti
AU
$28.6B
| $2.62M | 0.79% |
134,900
-75,100
| -36% | -$1.46M |
|
32
Fate Therapeutics
FATE
$120M
| $2.52M | 0.76% |
+250,000
| New | +$2.52M |
|
33
AdvisorShares Pure US Cannabis ETF
MSOS
$986M
| $2.45M | 0.74% |
350,000
+240,000
| +218% | +$1.68M |
|
34
Hecla Mining
HL
$5.7B
| $2.22M | 0.67% |
400,000
+200,000
| +100% | +$1.11M |
|
|
TSP
35
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $1.91M | 0.58% |
+1,166,146
| New | +$1.91M |
|
36
Sprott Physical Silver Trust
PSLV
$7.48B
| $1.9M | 0.57% |
230,000
| – | – |
|
|
NBIS
37
Nebius Group N.V. Class A Ordinary Shares
NBIS
$16.3B
| $1.56M | 0.47% |
105,000
| – | – |
|
|
MREO
38
Mereo BioPharma
MREO
$272M
| $1.54M | 0.46% |
2,049,661
+1,863,005
| +998% | +$1.4M |
|
39
Cue Biopharma
CUE
$60M
| $1.42M | 0.43% |
497,177
+38,326
| +8% | +$109K |
|
|
BIG
40
DELISTED
Big Lots, Inc.
BIG
| $1.39M | 0.42% |
+94,711
| New | +$1.39M |
|
41
Bausch Health
BHC
$2.74B
| $1.37M | 0.41% |
+217,500
| New | +$1.37M |
|
42
Sibanye-Stillwater
SBSW
$5.36B
| $1.33M | 0.4% |
124,358
| – | – |
|
43
Applied Optoelectronics
AAOI
$1.51B
| $990K | 0.3% |
523,867
+153,867
| +42% | +$291K |
|
44
Lumen
LUMN
$5.1B
| $914K | 0.28% |
+175,000
| New | +$914K |
|
45
Olema Pharmaceuticals
OLMA
$375M
| $861K | 0.26% |
351,517
+166,246
| +90% | +$407K |
|
46
Alico
ALCO
$259M
| $840K | 0.25% |
35,176
-11,521
| -25% | -$275K |
|
47
Galapagos
GLPG
$2.07B
| $829K | 0.25% |
18,678
+8,678
| +87% | +$385K |
|
48
Tilray
TLRY
$1.52B
| $740K | 0.22% |
+275,000
| New | +$740K |
|
49
Iovance Biotherapeutics
IOVA
$807M
| $735K | 0.22% |
+115,000
| New | +$735K |
|
50
Teva Pharmaceuticals
TEVA
$21.1B
| $684K | 0.21% |
75,000
-59,000
| -44% | -$538K |
|